CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The HydroTheC project aims to develop a thermo-responsive hydrogel for localized drug delivery in ovarian cancer treatment. This innovative system allows for controlled release of therapeutic agents directly at the site of tumor spread, potentially improving patient outcomes and minimizing systemic side effects.
Ovarian Cancer (OC) is usually diagnosed in advanced stages when metastasis into the intra-abdominal (i.a.) cavity already occurred.
The OC standard-of-care efficacy is hampered by drugs high systemic toxicity and the early appearance of resistance.
Thus, advanced OC remains an unmet clinical need, forcing the need for alternative therapies based on drugs local slow-release at the i.a. cavity.
Hydrogels (HG) have been proposed as in situ drug sustained release systems in the biomedical field.
Th…
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
